Monday 15 September 2014

Multiple sclerosis (relapsing remitting) - dimethyl fumarate: costing report

"The costing template can be used by health communities to assess the local impact of implementing the recommendations, based on the local population. The national assumptions used in the template can be altered to reflect local circumstances."

TA320 Multiple sclerosis (relapsing remitting) - dimethyl fumarate: costing report
NICE
August 2014

Read more here.

No comments:

Post a Comment